Literature DB >> 27913678

Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1.

Amanpreet Kaur1,2, Jukka Westermarck1,2.   

Abstract

Protein phosphatase 2A (PP2A) plays a major role in maintaining cellular signaling homeostasis by dephosphorylation of a variety of signaling proteins and acts as a tumor suppressor. Protein phosphatase methylesterase-1 (PME-1) negatively regulates PP2A activity by highly complex mechanisms that are reviewed here. Importantly, recent studies have shown that PME-1 promotes oncogenic MAPK/ERK and AKT pathway activities in various cancer types. In human glioma, high PME-1 expression correlates with tumor progression and kinase inhibitor resistance. We discuss the emerging cancer-associated function of PME-1 and its potential clinical relevance.
© 2016 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  LCMT-1; PTPA; colorectal cancer; endometrial cancer; glioma; neuroendocrine prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 27913678     DOI: 10.1042/BST20160161

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.

Authors:  Otto Kauko; Susumu Y Imanishi; Evgeny Kulesskiy; Laxman Yetukuri; Teemu Daniel Laajala; Mukund Sharma; Karolina Pavic; Anna Aakula; Christian Rupp; Mikael Jumppanen; Pekka Haapaniemi; Luyao Ruan; Bhagwan Yadav; Veronika Suni; Taru Varila; Garry L Corthals; Jüri Reimand; Krister Wennerberg; Tero Aittokallio; Jukka Westermarck
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

2.  Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice.

Authors:  Agnieszka Staniszewski; Hong Zhang; Kesava Asam; Rose Pitstick; Michael P Kavanaugh; Ottavio Arancio; Russell E Nicholls
Journal:  J Neurosci       Date:  2020-04-27       Impact factor: 6.167

3.  Polyomavirus Small T Antigen Induces Apoptosis in Mammalian Cells through the UNC5B Pathway in a PP2A-Dependent Manner.

Authors:  Sameer Ahmed Bhat; Zarka Sarwar; Syed Qaaifah Gillani; Misbah Un Nisa; Irfana Reshi; Nusrat Nabi; Shaozhen Xie; Khalid M Fazili; Thomas M Roberts; Shaida Andrabi
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

4.  PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

Authors:  Otto Kauko; Caitlin M O'Connor; Evgeny Kulesskiy; Jaya Sangodkar; Anna Aakula; Sudeh Izadmehr; Laxman Yetukuri; Bhagwan Yadav; Artur Padzik; Teemu Daniel Laajala; Pekka Haapaniemi; Majid Momeny; Taru Varila; Michael Ohlmeyer; Tero Aittokallio; Krister Wennerberg; Goutham Narla; Jukka Westermarck
Journal:  Sci Transl Med       Date:  2018-07-18       Impact factor: 17.956

5.  Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation.

Authors:  Yumei Zhou; Mengxuan Li; Yiquan Xue; Zhiqing Li; Weitao Wen; Xingguang Liu; Yuanwu Ma; Lianfeng Zhang; Zhongyang Shen; Xuetao Cao
Journal:  Cell Res       Date:  2019-06-18       Impact factor: 25.617

6.  Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.

Authors:  Ken Morita; Shuning He; Radosław P Nowak; Jinhua Wang; Mark W Zimmerman; Cong Fu; Adam D Durbin; Megan W Martel; Nicole Prutsch; Nathanael S Gray; Eric S Fischer; A Thomas Look
Journal:  Cell       Date:  2020-04-20       Impact factor: 66.850

7.  Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells.

Authors:  Cuiping Dai; Xuning Zhang; Da Xie; Peipei Tang; Chunmei Li; Yi Zuo; Baofei Jiang; Caiping Xue
Journal:  Oncotarget       Date:  2017-09-28

8.  The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.

Authors:  Dawid G Nowak; Ksenya Cohen Katsenelson; Kaitlin E Watrud; Muhan Chen; Grinu Mathew; Vincent D D'Andrea; Matthew F Lee; Manojit Mosur Swamynathan; Irene Casanova-Salas; Megan C Jibilian; Caroline L Buckholtz; Alexandra J Ambrico; Chun-Hao Pan; John E Wilkinson; Alexandra C Newton; Lloyd C Trotman
Journal:  J Cell Biol       Date:  2019-05-15       Impact factor: 10.539

9.  Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.

Authors:  Cuicui Yang; Xuelian Li; Wenbin Gao; Qi Wang; Li Zhang; Yali Li; Lin Li; Lan Zhang
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

10.  Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation.

Authors:  Jitendra Shrestha; Sung Hwan Ki; Sang Mi Shin; Seon Woong Kim; Joo-Youn Lee; Hee-Sook Jun; Taeho Lee; Sanghee Kim; Dong Jae Baek; Eun-Young Park
Journal:  Molecules       Date:  2018-10-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.